These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7750082)

  • 1. Characteristics of antitumor activity of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]- 2(1H)-quinolinone (vesnarinone) against a human adenoid squamous carcinoma-forming cell line grown in athymic nude mice.
    Sato M; Harada K; Bando T; Shirakami T; Nakashiro K; Yoshida H; Nakai S; Kawai K; Adachi M
    Cancer Lett; 1995 May; 91(1):1-9. PubMed ID: 7750082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.
    Sato M; Kawamata H; Harada K; Nakashiro K; Ikeda Y; Gohda H; Yoshida H; Nishida T; Ono K; Kinoshita M; Adachi M
    Cancer Lett; 1997 Jan; 112(2):181-9. PubMed ID: 9066726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of anticancer effects of radiation and conventional anticancer agents by a quinolinone derivative, vesnarinone: studies on human gastric cancer tissue xenografts in nude mice.
    Kawai K; Konishi Y; Izumi K; Sato M; Adachi M; Hozumi M
    Anticancer Res; 1998; 18(1A):405-12. PubMed ID: 9568110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of apoptosis in human choriocarcinoma cell lines by treatment with 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (vesnarinone).
    Isaka K; Fujito A; Sagawa Y; Yudate T; Nishi H; Ito H; Takayama M
    Oncol Rep; 2002; 9(6):1299-305. PubMed ID: 12375038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of tumour differentiation and apoptosis and LeY antigen expression in treatment with differentiation-inducing agent, vesnarinone, of a patient with salivary adenoid cystic carcinoma.
    Sato M; Harada K; Yura Y; Bando T; Azuma M; Kawamata H; Iga H; Yoshida H
    Apoptosis; 1997; 2(1):106-13. PubMed ID: 14646560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quinolinone derivative, vesnarinone (OPC-8212), significantly inhibits the in vitro and in vivo growth of human pancreatic cancer cell lines.
    Nio Y; Ohmori H; Minari Y; Hirahara N; Sasaki S; Takamura M; Tamura K
    Anticancer Drugs; 1997 Aug; 8(7):686-95. PubMed ID: 9311445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-inducing activity and growth suppression by vesnarinone on human glioma transplanted in nude mice.
    Tanaka S; Kawai K; Nakai S; Adachi M; Hori T
    Neurol Res; 1999 Jun; 21(4):409-14. PubMed ID: 10406015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of cyclin-dependent kinase inhibitor, p21waf1 gene by treatment with a differentiation inducing agent, vesnarinone in a human salivary gland cancer cell line.
    Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T; Kawamata H
    J Exp Clin Cancer Res; 2003 Mar; 22(1):57-60. PubMed ID: 12725323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The treatment with differentiation- and apoptosis-inducing agent, vesnarinone, of a patient with oral squamous cell carcinoma.
    Sato M; Harada K; Yura Y; Azuma M; Kawamata H; Iga H; Tsujimoto H; Yoshida H; Adachi M
    Apoptosis; 1997; 2(3):313-8. PubMed ID: 14646544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vesnarinone inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing the expression of vascular endothelial growth factor and interleukin-8.
    Harada K; Supriatno ; Yoshida H; Sato M
    Int J Oncol; 2005 Dec; 27(6):1489-97. PubMed ID: 16273203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (vesnarinone) on the growth of gastric cancer cell lines.
    Yokozaki H; Ito R; Ono S; Hayashi K; Tahara E
    Cancer Lett; 1999 Jun; 140(1-2):121-8. PubMed ID: 10403550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines.
    Kubo K; Matsuzaki Y; Kato A; Terai S; Okita K
    Int J Oncol; 1999 Jan; 14(1):41-6. PubMed ID: 9863007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vesnarinone downregulates CXCR4 expression via upregulation of Krüppel-like factor 2 in oral cancer cells.
    Uchida D; Onoue T; Begum NM; Kuribayashi N; Tomizuka Y; Tamatani T; Nagai H; Miyamoto Y
    Mol Cancer; 2009 Aug; 8():62. PubMed ID: 19671192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vesnarinone: a differentiation-inducing anti-cancer drug.
    Kawamata H; Omotehara F; Nakashiro K; Uchida D; Hino S; Fujimori T
    Anticancer Drugs; 2003 Jul; 14(6):391-5. PubMed ID: 12853878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line.
    Omotehara F; Kawamata H; Uchida D; Hino S; Nakashiro K; Fujimori T
    Br J Cancer; 2002 Oct; 87(9):1042-6. PubMed ID: 12434298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
    Kawamata H; Nakashiro K; Uchida D; Hino S; Omotehara F; Yoshida H; Sato M
    Br J Cancer; 1998; 77(1):71-8. PubMed ID: 9459148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
    Shalinsky DR; Bischoff ED; Gregory ML; Gottardis MM; Hayes JS; Lamph WW; Heyman RA; Shirley MA; Cooke TA; Davies PJ
    Cancer Res; 1995 Jul; 55(14):3183-91. PubMed ID: 7541715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cyclin-dependent kinase inhibitor p21 in vesnarinone-induced differentiation of squamous cell carcinoma cells.
    Yoneda K; Yamamoto T; Ueta E; Osaki T
    Cancer Lett; 1998 Nov; 133(1):35-45. PubMed ID: 9929158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of TSC-22 (transforming growth factor beta-stimulated clone 22) markedly enhances the growth of a human salivary gland cancer cell line in vitro and in vivo.
    Nakashiro K; Kawamata H; Hino S; Uchida D; Miwa Y; Hamano H; Omotehara F; Yoshida H; Sato M
    Cancer Res; 1998 Feb; 58(3):549-55. PubMed ID: 9458104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Suppression of granulopoiesis by vesnarinone].
    Chen G
    Kokubyo Gakkai Zasshi; 1996 Mar; 63(1):8-17. PubMed ID: 8725353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.